Please assess the completion status of the following clinical trial:

Trial Title: Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Persons who have provided written informed consent~* Age \> 18 years~* Patients with type 2 diabetes treated with insulin using a basal / bolus strategy for at least 6 months~* Doses of insulin \> 0.7 U / Kg / d~* HbA1c ≥ 7.5 %~* Without OAD for at least 4 weeks (sulfamides, Incretines, glinides, acarbose) except Metformin~* BMI ≥ 28.5 kg / m2~* Diabetes diagnosed for at least 10 years~* Patients able to monitor themselves and manage an insulin pump.~Exclusion Criteria:~* Patients treated with glitazones during the 3 months preceding inclusion~* Patients with proliferative ischemic retinopathy not treated by laser~* BMI \< 28.5 kg / m2~* Presence of implantable material ( CI MRI )~* Pacemaker ( CI MRI )~* Pregnancy, breast feeding~* Medically significant physical or psychiatric inability, patients under guardianship or wards of court~* The practice of violent sports~* Poor conditions of hygiene~* Professional environment of extreme cold or heat.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intensified multiple injections (Type: OTHER): None
- Pumps (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).